01 1Viatris
01 1TADALAFIL USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-31
Pay. Date : 2013-08-27
DMF Number : 20640
Submission : 2007-06-15
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TADALAFIL USP, with a corresponding US DMF Number 20640.
Remarkably, this DMF maintains an Active status since its submission on June 15, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2013, and payment made on August 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
